| Original language | English |
|---|---|
| Pages (from-to) | 287 - 287 |
| Number of pages | 1 |
| Journal | Breast Cancer Research and Treatment |
| Volume | 69 |
| Issue number | 3 |
| Publication status | Published - 2001 |
Survival benefit with Xeloda (capecitabine)/docetaxel vs docetaxel: analysis of post-study therapy.
D Miles, J P M Ayoub, J A O'Shaughnessy, G Cervantes, B Erikstein, M P N Findlay, V Gorbounova, S Rizel, S Verma, S J Vukelja
Research output: Contribution to journal › Meeting abstract
9
Citations
(Scopus)
